PRAXIS PRECISION MED

PRAX
Delayed Quote. Delayed  - 11/27 01:00:00 pm
40.86USD +9.96%
Prev.37.1600
Open37.6700
High40.9400
Low37.6700
Volume67 704
Latest news
4d ago
7d ago
7d ago
11/17
Chart PRAXIS PRECISION MEDICINES, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance39,939,937,4
Spread/Res.2,5%2,5%9,2%
Spread/Supp.30%30%15%
Support31,531,535,4
Financials
Sales 2020 - - -
Net income 2020 -53,7 M - -
Net Debt 2020 - - -
P/E ratio 2020 -19,3x
Yield 2020 -
Capitalization 1 421 M 1 421 M -
Capi. / Sales 2020 -
Capi. / Sales 2021 -
Nbr of Employees 51
Free-Float 98,7%
Company
Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal imbalance. Its development stage products include PRAX-114,...

>> Read more
Sector :
Biotechnology & Medical Research - NEC
Calendar :
No events available

Income Statement Evolution
Consensus
Mean consensus BUY
Number of Analysts 4
Average target price 53,33 $
Last Close Price 40,86 $
Spread / Highest target 59,1%
Spread / Average Target 30,5%
Spread / Lowest Target -2,10%